Y Zhuang, B G Wachall, R W Hartmann
Index: Bioorg. Med. Chem. 8(6) , 1245-52, (2000)
Full Text: HTML
The synthesis of a new series of P450 17 inhibitors is described. The imidazol-1-yl compounds 5 showed strong inhibition of P450 17 rat and especially human enzyme, the most active compounds being 5ax, 5ay and 5bx with IC50 values of 0.17, 0.24 and 0.25 microM, respectively (ketoconazole: 0.74 microM). The 1,2,4-triazol-1-yl compounds 6 were less active, while the 1,2,4-triazol-4-yl compounds 7 were inactive. The title compounds showed little inhibition of P450 arom. The most active P450 17 inhibitors 5ax and 5ay markedly decreased the testosterone plasma concentration of SD rats 2 h after application of 0.019 mmol/kg. After 6 h, 5ay still exhibited a strong effect.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
5-Bromoindanone
CAS:34598-49-7 |
C9H7BrO |
|
Discovery of a series of imidazo[4,5-b]pyridines with dual a...
2011-06-23 [J. Med. Chem. 54 , 4219-4233, (2011)] |
|
The identification of potent and selective imidazole-based i...
2006-01-15 [Bioorg. Med. Chem. Lett. 16(2) , 378-381, (2006)] |
|
Identification of a novel series of tetrahydrodibenzazocines...
2006-03-15 [Bioorg. Med. Chem. Lett. 16(6) , 1532-1536, (2006)] |
|
Asymmetric Strecker-Type Reaction of alpha-Aryl Ketones. Syn...
2001-01-01 [J. Org. Chem. 64(1) , 120-125, (1999)] |
|
Enzymatic Baeyer-Villiger Oxidation of Benzo-Fused Ketones: ...
[European J. Org. Chem. 2009(15) , 2526-2532, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
